Упрощенная HTML-версия
4Е10 and the hMAb combination 4E10/2F5/2G12 / C. Armbruster [et al.] //
J. Antimicrob. Chemother. —2004. —Vol. 54. —P. 915—920.
425. Passive immunoprophylaxis and therapy with humanized monoclonal antibody
specific for influenza A H5 hemagglutinin in mice / B. J. Hanson [et al.] // Respir.
Res.- 2 0 0 6 . -Vol. 7 . -P . 126.
426. PCR detection of Borrelia burgdorferi sensu lato, tick-borne encephalitis virus, and
human granulocytic ehrlichiosis agent in Ixodes persulcatus ticks from Western
Siberia, Russia / O.V. Morozova [et al.] // J. Clin. Microbiol. —2002. —Vol. 40,
№ 10. - P. 3802-3804.
427. Persistence of protective immunity following vaccination against tick-borne
encephalitis-longer than expected? / P. Rendi-Wagner [et al.] // Vaccine. - 2004. -
Vol. 22, № 21-22. - P.2743-2749.
428. Phylogenetic Analysis of the Chinese Rickettsia Isolate BJ-90 / J.Z. Zhang [et al.] //
Emerg. Infect. Dis. - 2000. - № 6, № 4. - P. 432-433.
429. Pierson, Th. C. Molecular mechanisms of antibody-mediated neutralisation of
flavivirus infection [Electronic resource] / Th. C. Pierson, M.S. Diamond // Exp.
Rev. Mol. Med. - 2008. - № 10. - Access mode : http: //joumals.cambridge.org/
action/ displayAbstract? fromPage =online&aid=1849564&fulltextType=RV&file
Id=S1462399408000665.
430. Pooled human IgG modulates cytocine production in lymphocytes and monocytes /
U. Anderson [et al.] // Immunol. Rev. - 1994. - Vol. 139. - P. 21-42.
431. Potent High-Afifinity Antibodies for Treatment and Prophylaxis of Respiratory
Syncytial Virus Derived from В Cells of Infected Patients / E. J. Collarini [et al.] //
J. Immunol. - 2009. - Vol. 183. - P. 6338-6345.
432. Potent neutralization ofHendraandNipah viruses by humanmonoclonal antibodies /
Z. Zhu [et al.] // J. Virol. - 2006. - Vol. 80. - P. 891-899.
433. Preparation and use of hyperimmune serum for prophylaxis and therapy of
Ebola virus infections / N. M. Kudoyarova-Zubavichene, N. N. Sergeyev,
A. A. Chepumov, S. V. Netesov // J. Inf. Dis. 1999. - Vol. 179 (Suppl. 1). -
P. 218-223.
434. Production and characterization of a human hyperimmune intravenous
immunoglobulin against Pseudomonas aeruginosa and Klebsiella species /
S. J. Cryz [et al.] // J. Infect. Dis. - 1991. - Vol. 163. - P.1055-1061.
435. Prophylactic and therapeutic efficacy of human intravenous immunoglobulin in
treating West Nile virus infection in mice / D. BenDNathan [et al.] // J. Infect.
D is.- 2 0 0 3 . -Vol. 188.-P . 5-12.
436. Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins
against West Nile virus / L. H. Gould [et al.] // J. Virol. - 2005. - Vol. 79. -
P. 14606-14613.
437. Pryor, M. J. The effects of site-directed mutagenesis on the dimerization and
secretion of the NS1 protein specified by dengue virus / M. J. Pryor, P. J. Wright//
Virology. - 1993. - Vol. 194. - P.769-780.
438. A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG)
vs. cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem
cell transplants (HSCT) / P. Zikos [et al.] // Haematologica. - 1998. - Vol. 83. -
P. 132-137.
227